WallStreetZenWallStreetZen

NASDAQ: PLSE
Pulse Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PLSE stock forecasts and price targets.

Forecast return on equity

Is PLSE forecast to generate an efficient return?

Company
-90.98%
Industry
19.39%
Market
360.87%
PLSE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PLSE forecast to generate an efficient return on assets?

Company
-77.53%
Industry
14.05%
PLSE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PLSE earnings per share forecast

What is PLSE's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.52
Avg 2 year Forecast
-$1.24

PLSE revenue forecast

What is PLSE's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$3.2M+3,606.98%
Avg 2 year Forecast
$11.2M+12,946.51%
PLSE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PLSE revenue growth forecast

How is PLSE forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
3,606.98%
Industry
18.74%
Market
1,542.52%
PLSE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PLSE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PLSE vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
PLSE$13.69N/AN/A
STAA$17.07$25.88+51.58%Buy
BLFS$22.02$32.00+45.32%Buy
EMBC$10.47$25.00+138.78%Strong Buy
AZTA$27.85$42.60+52.96%Buy
View Top Medical Stocks

Pulse Biosciences Stock Forecast FAQ

What is PLSE's earnings growth forecast for 2026-2027?

(NASDAQ: PLSE) Pulse Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 290.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,359.17%.

Pulse Biosciences's earnings in 2026 is -$74,733,000.On average, 4 Wall Street analysts forecast PLSE's earnings for 2026 to be -$103,338,780, with the lowest PLSE earnings forecast at -$110,244,296, and the highest PLSE earnings forecast at -$94,637,423.

In 2027, PLSE is forecast to generate -$84,329,974 in earnings, with the lowest earnings forecast at -$81,022,916 and the highest earnings forecast at -$86,810,267.

If you're new to stock investing, here's how to buy Pulse Biosciences stock.

What is PLSE's revenue growth forecast for 2026-2027?

(NASDAQ: PLSE) Pulse Biosciences's forecast annual revenue growth rate of 3,606.98% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 18.74%, and it is also forecast to beat the US market's average forecast revenue growth rate of 1,542.52%.

Pulse Biosciences's revenue in 2026 is $86,000.On average, 4 Wall Street analysts forecast PLSE's revenue for 2026 to be $216,043,039, with the lowest PLSE revenue forecast at $166,030,566, and the highest PLSE revenue forecast at $266,868,722.

In 2027, PLSE is forecast to generate $760,352,225 in revenue, with the lowest revenue forecast at $730,534,491 and the highest revenue forecast at $782,715,526.

What is PLSE's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: PLSE) forecast ROA is -77.53%, which is lower than the forecast US Medical Instruments & Supplies industry average of 14.05%.

What is PLSE's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: PLSE) Pulse Biosciences's current Earnings Per Share (EPS) is -$1.14. On average, analysts forecast that PLSE's EPS will be -$1.52 for 2026, with the lowest EPS forecast at -$1.63, and the highest EPS forecast at -$1.40. In 2027, PLSE's EPS is forecast to hit -$1.24 (min: -$1.20, max: -$1.28).

What is PLSE's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: PLSE) forecast ROE is -90.98%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.